Masahiro Natsuaki - Concepedia

Author

Masahiro Natsuaki

Also Known As

Erika Yamamoto, Hiroki Shiomi, Kaoru Dohi, Kohei Kaneta, M NATSUAKI, M Natsuaki, M. N. Natsuaki, M. Natsuaki, Masahiro NATSUAKI, Masahiro Natsuaki

223

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Kyoto University Kurashiki Central Hospital Saga University Kokura Memorial Hospital Hyogo Medical University

About

Masahiro Natsuaki is an author at Kyoto University specializing in cardiovascular disease, medicine, and coronary heart disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	29	738
2	Public Health	11	11	325
3	Emergency Medicine	7	7	144
4	Biomedical Engineering	1	1	30
5	Cardiothoracic Surgery	1	1	36

Masahiro Natsuaki

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, JAMA	2019	801
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, JAMA Cardiology	2022	275
Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent Masahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, Journal of the American College of Cardiology	2013	202
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores Masahiro Natsuaki, Takeshi Morimoto, Kyohei Yamaji, Journal of the American Heart Association	2018	190
Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents Takeshi Kimura, Takeshi Morimoto, Masahiro Natsuaki, Circulation	2012	155
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention Masahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, Circulation Cardiovascular Interventions	2019	127
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Circulation	2023	124
Long-Term Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion (from the CREDO-Kyoto Registry Cohort-2) Erika Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, The American Journal of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseHealth PolicyGlobal HealthOutcomes Research	2013	82
Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal Stent Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Circulation Cardiovascular Interventions	2014	77
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial Masahiro Natsuaki, Takeshi Morimoto, Erika Yamamoto, Cardiovascular Intervention and Therapeutics	2015	73

Page 1